Peers of Corbus Pharmaceuticals Holdings Inc (CRBP)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by trailing twelve-month revenue. A capital-structure-neutral sales valuation metric.
Latest EV/Sales
-320.75x
As of Sep 29, 2022
Beyond EV/Sales, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/Sales |
|---|---|
| Sep 29, 2022 | -320.75x |
| Sep 28, 2022 | -317.48x |
| Sep 27, 2022 | -344.31x |
| Sep 26, 2022 | -339.40x |
| Sep 23, 2022 | -325.67x |
| Sep 22, 2022 | -314.20x |
| Sep 21, 2022 | -306.26x |
| Sep 20, 2022 | -307.77x |
EV/Sales = Enterprise Value / Revenue (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/Sales is particularly useful in M&A analysis and for companies with significant debt.
Read the general EV/Sales definition, formula, and analyst usage guide.
EV/Sales guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison